Clinical significance of detection of cathepsin X and cystatin C in the sera of patients with lung cancer

Chinese Journal of Lung Cancer

Volumn 16, Issue 8, 2013, Pages 411-416

  Zhang, Xuede ^a   Hou, Yanli ^a   Niu, Zequn ^a   Li, Wei ^a   Meng, Xia ^a   Zhang, Na ^a   Yang, Shuanying ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cathepsin X; Cystatin C; Lung neoplasms; Sera

Indexed keywords

CATHEPSIN X; CYSTATIN C;

ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL;

ADULT; AGED; CASE-CONTROL STUDIES; CATHEPSINS; CYSTATIN C; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84881578654     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2013.08.04     Document Type: Article

References (33)

1. Strojan P. Cysteine cathepsins and stefins in head and neck cancer: an update of clinical studies. Radiol Oncol, 2008, 42(2): 69-81.
2. Ardebili SY, Zajc I, Gole B, et al. CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsins' expression in glioblastoma derived spheroids. Radiol Oncol, 2011, 45(2): 102-115.
3. Kos J, Lah TT. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep, 1998, 5(6): 1349-1361.
4. Kos J, Sekirnik A, Premzl A, et al. Carboxypeptidases cathepsins X and B display distinct protein profile in human cells and tissues. Exp Cell Res, 2005, 306(1): 103-113.
5. Kos J, Jevnikar Z, Obermajer N. The role of cathepsin X in cell signaling. Cell Adh Migr, 2009, 3(2): 164-166.
6. Obermajer N, Jevnikar Z, Doljak B, et al. CathepsinX-mediated ß2-integrin activation results in nanotube outgrowth. Cell Mol Life Sci, 2009, 66(6): 1126-1134.
7. Nascimento FD, Rizzi CC, Nantes IL, et al. Cathepsin X binds to cell surface heparan sulfate proteoglycans. Arch Biochem Biophys, 2005, 436(2): 323-332.
8. Krueger S, Kalinski T, Hundertmark T, et al. Up-regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer. J Pathol, 2005, 207(1): 32-42.
9. Nägler DK, Lechner AM, Oettl A, et al. An enzyme-linked immunosorbent assay for human cathepsin X, a potential new inflammatory marker. J Immunol Methods, 2006, 308(1-2): 241-250.
10. Baker AR, Zalwango S, Malone LL, et al. Genetic susceptibility to tuberculosis associated with cathepsin Z haplotype in a Ugandan household contact study. Hum Immunol, 2011, 72(5): 426-430.
11. Nagler DK, Kruger S, Kellner A, et al. Upregulation of Cathepsin X in prostate cancer and prostatic intraepithelial neoplasia. Prostate, 2004, 60: 109-119.
12. Rumpler G, Becker B, Hafner C, et al. Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes. Exp Dermatol, 2003, 12(6): 761-771.
13. Hidaka S, Yasutake T, Takeshita H, et al. Differences in 20q13.2 copy number between colorectal cancers with and without liver metastasis. Clin Cancer Res, 2000, 6(7): 2712-2717.
14. Bar-Shira A, Pinthus HJ, Rozovsky U, et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res, 2002, 62(23): 6803-6807.
15. Kos J, Werle B, Lah T, et al. Cysteine proteinases and their inhibitors in extracellular fluids: markers for diagnosis and prognosis in cancer. Int J Biol Markers, 2000, 15(1): 84-89.
16. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin, 2012, 62(1): 10-29.
17. Nägler DK, Zhang R, Tam W, et al. Human cathepsin X: A cysteine protease with unique carboxypeptidase activity. Biochemistry, 1999, 38(39): 12648-12654.
18. Vizin T, Christensen IJ, Nielsen HJ, et al. Cathepsin X in serum from patients with colorectal cancer: relation to prognosis. Radiol oncol, 2012, 46(3): 207-212.
19. Decock J, Obermajer N, Vozelj S, et al. CathepsinB, cathepsin H, cathepsin X and cystatin C in sera of patients with early-stage and inflammatory breast cancer. Int J Biol Markers, 2008, 23(3): 161-168.
20. Cox JL, Sexton PS, GreenTJ, et al. Inhibition of B16 melanoma metastasis by over expression of the cysteine proteinase inhibitor cystatin C. Melanoma Res, 1999, 9(4): 369-374.
21. Nishikawa H, Ozaki Y, Nakanishi T, et al. The role of Cathepsin B and Cystatin C in the mechanisms of invasion by ovarian cancer. Gynecol Oncol, 2004, 92(3): 881-886.
22. Saleh Y, Sebzda T, Warwas M, et al. Expression of cystatin C in clinical human colorectal cancer tissues. J Exp Ther Oncol, 2005, 5(1): 49-53.
23. Krepela E, Prochazka J, Karova B, et al. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma, 1998, 45(4): 318-331.
24. Wegiel B, Jiborn T, Abrahamson M, et al. Cystatin C is down regulated in prostate cancer and modulates invasion of prostate cancer cells via MAPK/Erk and androgen receptor pathways. PLoS One, 2009, 4(11): e7953.
25. Zore I, Krasovec M, CimermanN, et al. Cathepsin B/cystatin C complex levels in sera from patients with lung and colorectal cancer. Biol Chem, 2001, 382(5): 805-810.
26. Chen QY, Fei J, Wu L, et al. Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients. Oncol Lett, 2011, 2(4): 693-699.
27. Sevenich L, Schurigt U, Sachse K, et al. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci USA, 2010, 107(6): 2497-2502.
28. Wang J, Chen L, Li Y, et al. Overexpression of Cathepsin Z contributes to tumor metastasis by inducing epithelial-mesenchymal transition of hepatocellular carcinoma. PLoS One, 2011, 6(9): e24967.
29. Lines KE, Chelala C, Dmitrovic B, et al. S100P-binding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells. Am J Pathol, 2012, 180(4): 1485-1494.
30. Vigneswaran N, Wu J, Muller S, et al. Expression analysis of cystatin C and M in laser-capture microdissectioned human breast cancer cells-a preliminary study. Pathol Res Pract, 2005, 200(11-12): 753-762.
31. Kolwijck E, Kos J, Obermajer N, et al. The balance between extracellular cathepsins and cystatin C is of importance for ovarian cancer. Eur J Clin Invest, 2010, 40(7): 591-599.
32. Strojan P, Svetic B, Smid L, et al. Serum cystatin C in patients with head and neck carcinoma. Clin Chim Acta, 2004, 344(1-2): 155-161.
33. Kos J, Stabuc B, Schweiger A, et al. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients. Clin Cancer Res, 1997, 3(10): 1815-1822.